Table 3

Factors associated with the presence of steatosis

Absence of steatosis (n=155)Presence of steatosis (n=135)p Value
*Results are expressed as mean (SD).
BMI, body mass index; ALT, alanine aminotransferase; HCV, hepatitis C virus.
Sex (male, n (%))73 (52)70 (47)0.42
Age (n (%))0.04
    <50 y109 (70)73 (54)
    ⩾50 y46 (30)62 (46)
Age at infection (n (%))0.21
    <30 years65 (84)62 (77)
    ⩾3012 (16)19 (23)
Source of infection (n (%))0.23
    Blood transfusion33 (21)37 (27)
    Intravenous drug use46 (30)45 (33)
    Unknown76 (49)53 (39)
Duration of infection (n=155) (y)*19.4 (6.9)22.4 (7.6)0.01
Body mass index (kg/m2) (n (%))0.003
    Normal (BMI <25)103 (66)68 (50)
    Overweight (25⩽BMI<30)36 (23)42 (31)
    Obese (BMI ⩾30)4 (3)16 (12)
    Unknown12 (8)9 (7)
Alcohol consumption (n (%))0.29
    Absent106 (68)84 (62)
    Present43 (28)48 (36)
    Unknown6 (4)3 (2)
Tobacco consumption (n (%))0.58
    Absent79 (51)75 (56)
    Present64 (41)53 (39)
    Unknown12 (8)7 (5)
ALT (IU/l, median)78 (81)119 (83)0.0001
Glycaemia (mmol/l)*5.0 (1.3)5.7 (2.1)0.002
Cholesterol (mmol/l)*4.9 (1.1)4.7 (1.0)0.18
Triglycerides (mmol/l) (mmol/l)*1.1 (0.7)1.2 (0.8)0.17
HCV genotype (n (%))0.03
    319 (12)32 (24)
    Other114 (74)84 (62)
    Unknown22 (14)19 (14)
Grade (histology) (n (%))<0.0001
    A0–A1129 (83)83 (61)
    A2–A326 (17)52 (39)
Stage (histology) (n (%))<0.0001
    F0–F1111 (72)70 (52)
    F2–F3–F444 (28)65 (48)